SanBio Company Limited announced consolidated earnings results for the nine months ended October 31, 2019. For the nine months, the company reported operating revenue of JPY 424,344,000 against JPY 568,894,000 a year ago. Operating loss was JPY 3,628,823,000 against JPY 2,479,357,000 a year ago. Net loss was JPY 3,280,943,000 compared to JPY 1,549,448,000 a year ago. Net per share was JPY 64.47 per share JPY 32.19 per share a year ago.

For the full year ending January 31, 2020, the company now expects operating revenue of JPY 447 million compared to its previous issued guidance of JPY 713 million, operating loss of JPY 5,088 million compared to its previous issued guidance of JPY 5,887 million and net loss attributable to owners of parent of JPY 4,619 million or JPY 90.77 per share compared to its previous issued guidance of JPY 5,395 million or JPY 108.48 per share.